Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546948 · ClinicalTrials.gov registry record · Phase 4
Intraoperative Opioids and Postoperative Recovery After Hepatobiliary or Foregut Surgery
A Phase 4 study, sponsored by Endeavor Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT01546948 is a Phase 4 study that has completed, run by Endeavor Health. The registered enrollment target is 60 participants.
The verdict
NCT01546948, a Phase 4 study, has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary aim of this randomized, double-blind study is to examine the effect of a single intraoperative dose of methadone on analgesic requirements during the first three days after hepatobiliary or foregut surgery. These patients will be compared to subjects receiving a standard dose of the "traditional" intraoperative opioid (hydromorphone). Secondary outcome measures to be assessed will include postoperative pain scores and standard recovery variables such as hospital length of stay.
Interventions
- DRUG Methadone
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-08 |
| Est. Completion | 2018-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01546948
The ClinicalTrials.gov registry entry for NCT01546948 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methadone is the first listed.
NCT01546948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01546948 about?
NCT01546948 is a clinical study titled "Intraoperative Opioids and Postoperative Recovery After Hepatobiliary or Foregut Surgery". The primary aim of this randomized, double-blind study is to examine the effect of a single intraoperative dose of methadone on analgesic requirements during the first three days after hepatobiliary or foregut surgery. These patients will be compared to subjects receiving a standard dose of the "tra...
What is the current status of trial NCT01546948?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2011-08. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01546948?
The interventions under investigation include: Methadone (DRUG), Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT01546948?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.